Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 545 Lymphoma 444 Precursor Cell Lymphoblastic Leukemia-Lymphoma 409 Lymphoma, Large B-Cell, Diffuse 347 Leukemia 344 Multiple Myeloma 335 Lymphoma, Non-Hodgkin 316 Leukemia, Myeloid, Acute 288 Leukemia, Lymphocytic, Chronic, B-Cell 285 Lymphoma, Follicular 240 Burkitt Lymphoma 217 Myelodysplastic Syndromes 209 Lymphoma, Mantle-Cell 201 Hodgkin Disease 193 Recurrence 153 Lymphoma, B-Cell, Marginal Zone 142 Melanoma 135 Lymphoma, Large-Cell, Immunoblastic 116 Neoplasms 109 Lymphoma, B-Cell 103 Neuroblastoma 101 Neoplasms, Plasma Cell 99 Ovarian Neoplasms 96 Triple Negative Breast Neoplasms 93 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91 Myeloproliferative Disorders 87 Hematologic Neoplasms 87 Leukemia, Myeloid, Chronic-Phase 83 Leukemia, Myeloid, Accelerated Phase 80 Leukemia, Myelomonocytic, Chronic 78

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Neoplasm × Cyclophosphamide × Clear all

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡